Oncology / Cancer Collection home page

Browse
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 64
 next >
YearTitleAuthor(s)
Jul-1998Diagnosis and investigation of headacheSturm, Jonathan; Donnan, G.A.
Feb-1999Uterine cancer presenting with generalised dysaesthesia--a possible new paraneoplastic syndrome?Sturm, Jonathan; Macdonell, R.A.; Newton, M.R.
Aug-2018Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesForsyth, Cecily J; Godfrey, A.L.; Campbell, P.J.; MacLean, C.; Buck, G.; Cook, J.; Temple, J.; Wilkins, B.S.; Wheatley, K.; Nangalia, J.; Grinfeld, J.; McMullin, M.F.; Kiladjian, J.J.; Green, A.R.; Harrison, C.N.
Dec-2018The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complicationsForsyth, Cecily J; Melville, K.; Tiley, Campbell
Apr-2018Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaForsyth, Cecily J; Crassini, K.R.; Zhang, E.; Balendran, S.; Freeman, J.A.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P.
May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaForsyth, Cecily J; Fox, L.C.; Cummins, K.D.; Costello, B.; Yeung, D.; Cleary, R.; Tatarczuch, M.; Burbury, K.; Motorna, O.; Shortt, J.; Fleming, S.; McQuillan, A.; Schwarer, A.; Harrup, R.; Holmes, A.; Ratnasingam, S.; Chan, K.L.; Hsu, W.H.; Ashraf, A.; Putt, F.; Grigg, A.
Mar-2017A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisForsyth, Cecily J; ForHo, P.J.; Bajel, A.; Burbury, K.; Dunlop, L.; Durrant, S.; Perkins, A.C.; Ross, D.M.
May-2017Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite studyForsyth, Cecily J; Quach, H; Fernyhough, L.; Henderson, R.; Corbett, G.; Baker, B.; Browett, P.; Blacklock, H.; Underhill, C.; Cannell, P.; Trotman, J.; Neylon, A.; Harrison, S.; Link, E.; Swern, A.; Cowan, L.; Dimopoulos, M.A.; Miles Prince, H.
Apr-2016Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasmsForsyth, Cecily J; Malherbe, J.A.; Fuller, K.A.; Mirzai, B.; Kavanagh, S.; So, C.C.; Ip, H.W.; Guo, B.B.; Howman, R.; Erber, W.N.
May-2014Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyureaForsyth, Cecily J; Verner, E.; Grigg, A.
Jan-2013Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaForsyth, Cecily J; Freeman, J.A.; Crassini, K.R.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P.
Aug-2016Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortForsyth, Cecily J; Campbell, P.J.; MacLean, C.; Beer, P.A.; Buck, G.; Wheatley, K.; Kiladjian, J.J.; Harrison, C.N.; Green, A.R.
Oct-2018Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer CentreBack, Michael F; Jayamanne, Dasantha; Wong, Matthew H; Cove, N.; Wheeler, H.; Khasraw, M.; Guo, L.; Back, J.
Sep-2018Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with GliomaBack, Michael F; Jayamanne, Dasantha; Rodriguez, M.; Khasraw, M.; Lee, A.; Wheeler, H.
Nov-2018Recommendations for the use of pegylated interferon-alpha in the treatment of classical myeloproliferative neoplasmsForsyth, Cecily J; Chan, Wai-Hoong; Grigg, A.; Cook, N.C.; Lane, S.W.; Burbury, K.; Perkins, A.C.; Ross, D.M.
Jan-2014Cognitive Deficits in Primary Brain Tumours: A Framework for Management and RehabilitationBack, Michael F; Back, E.; Wheeler, H.; Kastelan, M.
Dec-2013Dosimetric Improvements Utilising Intensity Modulated Radiation Therapy for Patients with Glioblastoma MultiformeBack, Michael F; Eade, Thomas; Clifford, S.; Wheeler, H.
Jul-2017Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyBack, Michael F; Jayamanne, Dasantha; Harris, G.; Wheeler, H.; Gzell, C.; Kastelan, M.; Schembri, G.; Brazier, D.; Cook, R.; Parkinson, J.; Khasraw, M.; Louw, S.
Mar-2017Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaBack, Michael F; Perry, J.R.; Laperriere, N.; O'Callaghan, C.J.; Brandes, A.A.; Menten, J.; Phillips, C.; Fay, M.; Nishikawa, R.; Cairncross, J.G.; Roa, W.; Osoba, D.; Rossiter, J.P.; Sahgal, A.; Hirte, H.; Laigle-Donadey, F.; Franceschi, E.; Chinot, O.; Golfinopoulos, V.; Fariselli, L.; Wick, A.; Feuvret, L.; Tills, M.; Winch, C.; Baumert, B.G.; Wick, W.; Ding, K.; Mason, W.P.
Jul-2018Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaJayamanne, Dasantha; Back, Michael F; Kaushal, Sneha; Hayes, A.R.; Hsiao, E.; Schembri, G.; Bailey, D.; Roach, P.J.; Khasraw, M.; Newey, A.; Wheeler, H.R.
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 64
 next >